"10.1371_journal.pone.0149549","plos one","2016-03-24T00:00:00Z","Sophie R Sayers; Frank Reimann; Fiona M Gribble; Helen Parker; Sagen Zac-Varghese; Stephen R Bloom; Marc Foretz; Benoit Viollet; Guy A Rutter","Department of Cell Biology and Functional Genomics, Imperial College London, London, W12 ONN, United Kingdom; Wellcome Trust - MRC Institute of Metabolic Science, University of Cambridge, Hills Road, Cambridge, CB2 0QQ, United Kingdom; Department of Investigative Medicine, Imperial College London, London, W12 ONN, United Kingdom; INSERM, U1016, Institut Cochin, 75014 Paris, France; CNRS, UMR8104, 75014 Paris, France; Université Paris Descartes, Sorbonne Paris Cité, 75014 Paris, France","Conceived and designed the experiments: GAR SZ-V SRB. Performed the experiments: SRS HP SZ-V. Analyzed the data: FR FMG GAR. Contributed reagents/materials/analysis tools: MF BV FMG. Wrote the paper: SRS GAR FMG BV.","The authors have the following interests. SZ-V received a Merck Sharp & Dohme (MSD)/European Foundation for the Study of Diabetes (EFSD, http://www.europeandiabetesfoundation.org/) award. Financial support was provided by the pharmaceutical company, Astra Zeneca, under the terms of the IMIDIA consortium. There are no patents, products in development or marketed products to declare. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.","2016","03","Sophie R Sayers","SRS",9,TRUE,3,3,3,4,TRUE,FALSE,FALSE,0,NA,FALSE
